Stacey McCullough, PharmD, senior vice president of pharmacy at Tennessee Oncology, discusses the importance of the pharmacist there are more advances being made and therapeutic options becoming available in oncology.
Stacey McCullough, PharmD, senior vice president of pharmacy at Tennessee Oncology, discusses the importance of the pharmacist there are more advances being made and therapeutic options becoming available in oncology.
Transcript
How is the role of pharmacists changing with the shift from infused to oral therapies?
It’s a great opportunity for pharmacy to play a more active role in being a care provider rather than just being a service provider. In the IV distribution system, pharmacists may be doing ad-mixture, drug information, but not an active role a lot of times in the actual patient care. With the oral oncolytics and the patients doing their own therapy at home, it’s a great opportunity for pharmacy to be a part of the actual care team, have that patient interaction and be that conduit for the patient and following up on a routine basis, managing through their side effects, and communicating that information back into the provider.
Do the expectations that clinicians and patients have of the pharmacist’s role in patient care differ for IV therapy vs oral therapy?
I think for the oral therapy that does really give the pharmacy a larger opportunity to play a role in the overall care of the patient. The phone calls that will be made to the patient, both for symptom management proactively and we have care plans that are developed that are time specifically for when we anticipate the patient to have side effects occur with the medication. Or, the adherence calls that are made for refill. We want to have those interactions be informational to build a relationship with the patient and be that source of information back into the provider in those time intervals in which they are not actively being seen.
Why is teamwork and collaboration especially important in oncology?
The number of new medications that are being approved are at unprecedented times I think in oncology. The advances being made and therapeutic options, that gives a lot of opportunity for pharmacy to play a key role, not only in information about new medications being approved, but also when we look at the number of oral oncolytics being developed, pharmacy is gonna play a key role in getting those patients started on their medication. A lot of times, the patient access as well as the financial assistance is done through the pharmacy team for oral oncolytics. Also, then the pharmacists will be the educators as well as the adherence contact for the patient to continue on their therapy.
Study Links COVID-19 Pandemic to Rise in Neoadjuvant Chemotherapy for Ovarian Cancer in US
April 17th 2024There was greater use of neoadjuvant chemotherapy among US patients with ovarian cancer (OC) during the COVID-19 pandemic to reduce potential COVID-19 exposure and cancer treatment-related complications.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
The Biden administration recently launched the Global Health Security Strategy, a new effort to combat the spread of infectious diseases; lawmakers zeroed in on the risks of massive consolidation in health care during the first congressional hearing on the Change Healthcare hack; the FDA recently announced the recall of a pair of heart devices linked to numerous deaths and injuries.
Read More
Need for Pharmacogenomic Testing in Mental Health Care Explored at AMCP 2024
April 17th 2024Presenters from Mayo Clinic discussed the benefits of implementing pharmacogenomic testing in mental health care for the betterment of patient outcomes, reducing medical costs, and more at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting.
Read More